OSMT – priming for a buyout via /r/wallstreetbets #stocks #wallstreetbets #investing

Osmotica Pharmaceuticals (NASDAQ:OSMT) seems to be ramping up for a buyout.

OSMT has created eye drops RVL-1201 (non-surgical) solution for drooping eye lid condition. This condition occurs due to partial or complete dysfunction of the muscles. Currently, patients have to undergo complex medical surgery to fix drooping eye condition. Eye drops/drug will activate Mueller muscle to fix drooping eye lid condition. Few Analysts have PT of $9-$10.

Recent event 11/20 & 11/23:

• 4,936,926 shares were "disposed" for $0 a share. Which is the equivalent of a reverse dilution: http://www.conferencecalltranscripts.org/4/summary2/?id=8595420

• At the same time major tutes increased their position:

  • Avista Capital Partners III GP, L.P. bumps its position to 25.2% of OSMT

Buried in the SEC 13D/A released yesterday (11/23): Item 4. Purpose of Transaction. (page 7) : The Company disclosed that this review will also include the initiation of a process for the sale of the Company.

Note that this is good timing for acquisition as they had an approved PDUFA on 7/16 and have one coming up for 12/29 for arbaclofen.